5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia

Details for Australian Patent Application No. 2003300014 (hide)

Owner ARENA PHARMACEUTICALS, INC.

Inventors Averbuj, Claudia; Semple, Graeme; Shin, Young-Jun; Gharbaoui, Tawfik; Skinner, Philip

Agent FB Rice

Pub. Number AU-A-2003300014

PCT Number PCT/US2003/0321

PCT Pub. Number WO2004/032928

Priority 60/418,057 10.10.02 US

Filing date 9 October 2003

Wipo publication date 4 May 2004

International Classifications

A61K 031/45 - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

C07D 231/16 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/14 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/418,057 10.10.02 US

3 June 2004 Application Open to Public Inspection

  Published as AU-A-2003300014

6 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300015-CELLULOSE FILM LABEL WITH TACTILE FEEL

2003300013-METHOD AND APPARATUS FOR MONITORING OF DIASTOLIC HEMODYNAMICS